ZEB1 and breast cancer: In breast cancer, high expression of the EMT-inducer ZEB1 is strongly correlated with the estrogen receptor (ER) negative claudin-low subtype, which shows an intrinsic EMT phenotype, whereas its expression is very low in ER positive breast cancer cases [15, 16].